STAAR Surgical Company
STAA
$19.23
$0.190.97%
NASDAQ
| 09/26/2025 | 06/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 113.75% | 4.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 113.75% | 4.06% | |||
| Cost of Revenue | 46.32% | -21.00% | |||
| Gross Profit | 137.43% | 17.12% | |||
| SG&A Expenses | -6.42% | -3.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.82% | -10.73% | |||
| Operating Income | 199.38% | 28.90% | |||
| Income Before Tax | 172.51% | 52.44% | |||
| Income Tax Expenses | 208.82% | -3,210.18% | |||
| Earnings from Continuing Operations | 152.84% | 68.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 152.84% | 68.99% | |||
| EBIT | 199.38% | 28.90% | |||
| EBITDA | 216.86% | 29.87% | |||
| EPS Basic | 152.72% | 69.10% | |||
| Normalized Basic EPS | 219.48% | 35.30% | |||
| EPS Diluted | 152.65% | 69.09% | |||
| Normalized Diluted EPS | 217.29% | 35.30% | |||
| Average Basic Shares Outstanding | 0.23% | 0.36% | |||
| Average Diluted Shares Outstanding | 2.08% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||